Stay updated on Nivolumab in Hodgkin Lymphoma Clinical Trial

Sign up to get notified when there's something new on the Nivolumab in Hodgkin Lymphoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab in Hodgkin Lymphoma Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    Change Detected
    Summary
    The study page now states that no participants are being sought and adds guidance sections (How to Read a Study Record, Common Questions, How to Join a Study) along with an updated revision note (Revision: v3.6.0). The Intervention/Treatment header formatting was adjusted (Intervention/Treatment added and Intervention / Treatment removed).
    Difference
    0.3%
    Check dated 2026-06-13T17:39:33.000Z thumbnail image
  3. Check
    18 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.5.5, indicating a minor update to the study record rather than substantive content changes.
    Difference
    0.0%
    Check dated 2026-06-06T14:20:21.000Z thumbnail image
  4. Check
    26 days ago
    Change Detected
    Summary
    A Publications section was added, listing a Haematologica article about Nivolumab with or without vinblastine for elderly Hodgkin lymphoma, and noting that such publications are automatically filled from PubMed.
    Difference
    0.2%
    Check dated 2026-05-30T12:19:45.000Z thumbnail image
  5. Check
    40 days ago
    Change Detected
    Summary
    The page now references revision v3.5.4 instead of v3.5.3, signaling a backend/UI update without changes to the trial details or core content.
    Difference
    0.0%
    Check dated 2026-05-16T00:00:25.000Z thumbnail image
  6. Check
    61 days ago
    Change Detected
    Summary
    The page’s footer shows an updated site/system software revision from v3.5.2 to v3.5.3, without altering the underlying study details.
    Difference
    0.0%
    Check dated 2026-04-24T17:10:48.000Z thumbnail image
  7. Check
    68 days ago
    Change Detected
    Summary
    Added Revision: v3.5.2; removed Revision: v3.5.0.
    Difference
    0.0%
    Check dated 2026-04-17T13:42:53.000Z thumbnail image

Stay in the know with updates to Nivolumab in Hodgkin Lymphoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab in Hodgkin Lymphoma Clinical Trial page.